The Impact of Percutaneous Tracheotomy on Mortality and Length of Stay in the Critical Care Unit for COVID-19 ARDS

  • Abstract
  • Literature Map
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

ABSTRACTObjective:The aim of this study was to investigate the effect of percutaneous tracheotomy on mortality and length of stay in the intensive care unit (ICU) for patients with COVID-19-associated acute respiratory distress syndrome (ARDS).Materials and Methods:This study included patients with coronavirus disease-19 (COVID-19-associated) acute respiratory distress syndrome who were treated with invasive mechanical ventilation in a pandemic intensive care unit. Patients admitted to the pandemic intensive care unit between March and July 2021 were retrospectively reviewed. Patients who underwent percutaneous tracheotomy and did not have a tracheotomy during the follow-up were statistically compared in terms of laboratory and clinical characteristics such as mortality and length of stay in the intensive care unit.Results:The study included 102 orotracheally intubated patients diagnosed with COVID-19 acute respiratory distress syndrome. The number of tracheotomized and not-tracheotomized patients was 34 and 68, respectively. The mean age of the patients was 60.39±14.10 years. The mean time to perform percutaneous tracheotomy was 7.94±6.11 days. There was no significant difference in mortality rate between the two groups (p=0.298). However, patients who underwent tracheotomy had a longer length of stay in the intensive care unit compared to those who did not (35.00±24.60 days vs 13.20±11.69 days, p<0.001).Conclusion:Our study found no statistically significant difference in mortality rate between the two groups in our study. Additionally, the length of stay in the intensive care unit was not better in tracheotomized patients. While tracheotomy has some advantages in other severe lung diseases, its effect on mortality in patients with severe lung disease associated with COVID-19 should be evaluated further in randomized controlled trials.

Similar Papers
  • Discussion
  • Cite Count Icon 11
  • 10.1053/j.jvca.2020.07.070
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?
  • Jul 30, 2020
  • Journal of Cardiothoracic and Vascular Anesthesia
  • Samiha Alom + 4 more

Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?

  • Front Matter
  • Cite Count Icon 3
  • 10.1053/j.jvca.2021.05.059
Protecting the Injured Right Ventricle in COVID-19 Acute Respiratory Distress Syndrome: Can Clinicians Personalize Interventions and Reduce Mortality?
  • Jun 5, 2021
  • Journal of Cardiothoracic and Vascular Anesthesia
  • Vasileios Zochios + 3 more

Protecting the Injured Right Ventricle in COVID-19 Acute Respiratory Distress Syndrome: Can Clinicians Personalize Interventions and Reduce Mortality?

  • Discussion
  • Cite Count Icon 55
  • 10.1016/j.bja.2020.10.011
Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome
  • Oct 14, 2020
  • BJA: British Journal of Anaesthesia
  • Alessia Longobardo + 5 more

Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome

  • Discussion
  • Cite Count Icon 3
  • 10.1002/ejhf.2087
COVID-19 acute respiratory distress syndrome: intriguing haemodynamics of an intriguing syndrome.
  • Jan 7, 2021
  • European journal of heart failure
  • Nick Smith + 1 more

COVID-19 acute respiratory distress syndrome: intriguing haemodynamics of an intriguing syndrome.

  • Front Matter
  • Cite Count Icon 28
  • 10.1053/j.jvca.2020.04.060
Role of Helmet-Delivered Noninvasive Pressure Support Ventilation in COVID-19 Patients
  • May 8, 2020
  • Journal of Cardiothoracic and Vascular Anesthesia
  • Richard J Ing + 5 more

Role of Helmet-Delivered Noninvasive Pressure Support Ventilation in COVID-19 Patients

  • Front Matter
  • Cite Count Icon 17
  • 10.1053/j.jvca.2020.11.062
Indications for Tracheal Intubation in Patients With Coronavirus Disease 2019 (COVID-19)
  • Dec 2, 2020
  • Journal of Cardiothoracic and Vascular Anesthesia
  • Antonio Pisano + 3 more

Indications for Tracheal Intubation in Patients With Coronavirus Disease 2019 (COVID-19)

  • Front Matter
  • Cite Count Icon 3
  • 10.1053/j.jvca.2021.04.044
Essential Topics in the Management of Venovenous Extracorporeal Membrane Oxygenation in COVID-19 Acute Respiratory Distress Syndrome
  • May 8, 2021
  • Journal of Cardiothoracic and Vascular Anesthesia
  • Asad Ali Usman + 1 more

Essential Topics in the Management of Venovenous Extracorporeal Membrane Oxygenation in COVID-19 Acute Respiratory Distress Syndrome

  • Discussion
  • Cite Count Icon 14
  • 10.1016/j.bja.2020.08.047
Outcomes in mechanically ventilated patients with hypoxaemic respiratory failure caused by COVID-19
  • Sep 3, 2020
  • BJA: British Journal of Anaesthesia
  • Luigi Camporota + 5 more

Outcomes in mechanically ventilated patients with hypoxaemic respiratory failure caused by COVID-19

  • Research Article
  • Cite Count Icon 56
  • 10.1111/obr.13089
Effect of obesity and body mass index on coronavirus disease 2019 severity: A systematic review and meta-analysis.
  • Sep 14, 2020
  • Obesity Reviews
  • Tu‐Hsuan Chang + 2 more

We conducted a systematic review of observational studies to examine the effects of body mass index (BMI) and obesity (BMI ≥ 30 kg/m2 ) on coronavirus disease 2019 (COVID-19). Medline, Embase, and the Cochrane Library were searched. Sixteen articles were finally included in the meta-analysis, and a random effects model was used. BMI was found to be higher in patients with severe disease than in those with mild or moderate disease (MD 1.6, 95% CI, 0.8-2.4; p = .0002) in China; however, the heterogeneity was high (I2 = 75%). Elevated BMI was associated with invasive mechanical ventilation (IMV) use (MD 4.1, 95% CI, 2.1-6.1; p < .0001) in Western countries, and this result was consistent across studies (I2 = 0%). Additionally, there were increased odds ratios of IMV use (OR 2.0, 95% CI, 1.4-2.9; p < .0001) and hospitalization (OR 1.4, 95% CI, 1.3-1.60; p < .00001) in patients with obesity. There was no substantial heterogeneity (I2 = 0%). In conclusion, obesity or high BMI increased the risk of hospitalization, severe disease and invasive mechanical ventilation in COVID-19. Physicians must be alert to these early indicators to identify critical patients.

  • Front Matter
  • Cite Count Icon 130
  • 10.1016/j.bja.2020.06.013
COVID-19: a complex multisystem disorder
  • Jun 20, 2020
  • British Journal of Anaesthesia
  • C Michael Roberts + 5 more

COVID-19: a complex multisystem disorder

  • Abstract
  • Cite Count Icon 2
  • 10.1016/j.chest.2020.09.162
ARDS RELATED TO COVID-19
  • Oct 1, 2020
  • Chest
  • Jasmine Sekhon + 3 more

ARDS RELATED TO COVID-19

  • Front Matter
  • Cite Count Icon 8
  • 10.1002/phar.2394
COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.
  • May 1, 2020
  • Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
  • Kathleen A Stringer + 3 more

COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.

  • Front Matter
  • Cite Count Icon 17
  • 10.1016/j.jtcvs.2021.06.061
Lung transplantation for coronavirus disease 2019 (COVID-19): The who, what, where, when, and why
  • Jul 6, 2021
  • The Journal of Thoracic and Cardiovascular Surgery
  • Lara Schaheen + 3 more

Lung transplantation for coronavirus disease 2019 (COVID-19): The who, what, where, when, and why

  • Front Matter
  • Cite Count Icon 18
  • 10.1053/j.jvca.2021.01.014
The Right Ventricle in COVID-19 Lung Injury: Proposed Mechanisms, Management, and Research Gaps
  • Jan 15, 2021
  • Journal of Cardiothoracic and Vascular Anesthesia
  • Graziella Isgro + 2 more

The Right Ventricle in COVID-19 Lung Injury: Proposed Mechanisms, Management, and Research Gaps

  • Research Article
  • Cite Count Icon 86
  • 10.1111/ajt.16176
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience.
  • Aug 2, 2020
  • American Journal of Transplantation
  • Nicola Bossini + 21 more

Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience.

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.

Search IconWhat is the difference between bacteria and viruses?
Open In New Tab Icon
Search IconWhat is the function of the immune system?
Open In New Tab Icon
Search IconCan diabetes be passed down from one generation to the next?
Open In New Tab Icon